0001567619-20-020724.txt : 20201207 0001567619-20-020724.hdr.sgml : 20201207 20201207180725 ACCESSION NUMBER: 0001567619-20-020724 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201203 FILED AS OF DATE: 20201207 DATE AS OF CHANGE: 20201207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KING THOMAS BRAXTON CENTRAL INDEX KEY: 0001279309 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39041 FILM NUMBER: 201373780 MAIL ADDRESS: STREET 1: 91 JAMES AVENUE CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001692830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813039831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 BUSINESS PHONE: 415-505-0809 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 4 1 doc1.xml FORM 4 X0306 4 2020-12-03 0 0001692830 Satsuma Pharmaceuticals, Inc. STSA 0001279309 KING THOMAS BRAXTON C/O SATSUMA PHARMACEUTICALS, INC. 400 OYSTER POINT BOULEVARD, SUITE 221 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 4.60 2020-12-03 4 A 0 20000 0.00 A 2030-12-03 Common Stock 20000 20000 D The option shall vest in full and become exercisable on the day immediately preceding the 2022 Annual Meeting. /s/ Thomas P. O'Neil as Attorney in Fact for Thomas B. King 2020-12-07